summary In this episode of Drug Diaries, host Kaushik Trivedi speaks with Amir Hefni, CEO of Resolution Therapeutics, about groundbreaking innovations in treating chronic liver disease through macrophage cell therapy. They discuss the recent funding success, the science behind the therapy, the challenges of clinical trials, and the importance of leadership and teamwork in biotech. Amir shares insights on the future of cell therapy, advice for aspiring entrepreneurs, and his personal passion for boxing, which influences his leadership style. Takeaways Chronic liver disease is a major global health issue. Resolution Therapeutics is pioneering macrophage cell therapy. Recent funding will accelerate clinical programs and manufacturing. The science behind macrophages focuses on reducing inflammation. Clinical trials are crucial for proving safety and efficacy. Leadership in biotech requires a strong, diverse team. Challenges in cell therapy include manufacturing and regulatory hurdles. Aspiring entrepreneurs should think about commercialization early. Cell therapy has transformative potential for various diseases. Personal passions can enhance leadership effectiveness. titles The Science Behind Healing the Liver Innovations in Macrophage Cell Therapy Sound Bites "Revolutionize how we treat chronic liver disease" "Harnessing the power of immune cells" "$63.5 million in series B financing" Chapters 00:00 Introduction to Chronic Liver Disease and Innovations 02:31 Funding and Future Goals of Resolution Therapeutics 05:37 The Science Behind Macrophage Cell Therapy 11:10 Clinical Trials and Patient Treatment Process 15:21 Leadership and Team Dynamics in Biotech 19:24 Challenges in Translating Research to Clinical Application 23:41 Advice for Aspiring Biotech Entrepreneurs 24:38 The Future of Cell Therapy in Inflammatory Conditions 26:32 Message to Patients and Commitment to Care 27:54 Personal Insights: Boxing and Leadership Lessons